Institut Curie, a leading cancer research centre in France, has introduced a surgical robotic system as part of a two-year clinical study partnership with CMR Surgical.
CMR’s Versius system will initially be dedicated to gynaecological cancer surgery with a focus on minimally invasive hysterectomies.
The partnership with CMR Surgical brings Institut Curie into the field of robotics research through two new clinical studies.
The first study will compare conventional and robotic-assisted surgery to assess the benefits of robotic surgery for hysterectomy operations and to study how the use of robotic surgery could change the eligibility of patients for hysterectomy.
The second study will focus on the ergonomics offered by Versius.
Dr Olivier Choussy, head of the Institut Curie’s oncological surgery department, said: “The benefits of robotic surgery are numerous, especially for patients.
“There is a reduction in post-operative pain and the risk of complications, and better long-term tolerance after laparotomies.
“And from the point of view of practitioners and carers, our practice will be greatly enriched, and the intervention time will be more efficient.
“The arrival of this assistive technology is a real step forward for the whole operating room.”
What’s more, Versius collects data throughout the procedure to deliver insights that can help surgeons and hospitals deliver better surgical care.
